Veracyte
VCYT
75 hedge funds and large institutions have $231M invested in Veracyte in 2018 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 19 reducing their positions, and 17 closing their positions.
69% more capital invested
Capital invested by funds: $137M → $231M (+$94.4M)
58% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 19
0.28% more ownership
Funds ownership: 71.86% → 72.14% (+0.28%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
6% less funds holding
Funds holding: 80 → 75 (-5)
29% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 17
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$6.68M |
| 2 |
CC
Cannell Capital
Alta,
Wyoming
|
+$2.48M |
| 3 |
BlackRock
New York
|
+$1.96M |
| 4 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$1.62M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$1.34M |
Top Sellers
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$4.63M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$4.3M |
| 3 |
BC
Broadfin Capital
New York
|
-$3.34M |
| 4 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
-$1.85M |
| 5 |
First Manhattan
New York
|
-$1.52M |
VCYT Hedge Fund Activity: Q2 2018 in Review
75 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2018, worth a combined $231M — up 69% from $137M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of VCYT and 12 opened new positions — a net loss of 5 holders — while 19 trimmed existing stakes and 30 added.
The largest buyer was ARK Investment Management, adding an estimated $6.68M. The largest seller was Acuta Capital Partners, cutting an estimated $4.63M.
- 75 institutional investors held Veracyte (VCYT) as of Q2 2018, down from 80 in Q1 2018.
- Funds reported $231M of Veracyte stock for Q2 2018, up 69% quarter-over-quarter.
- 12 funds opened new Veracyte positions in Q2 2018 and 17 closed out, a net change of -5 holders.
- The largest Veracyte buyer in Q2 2018 was ARK Investment Management, an estimated $6.68M added.
- The largest Veracyte seller in Q2 2018 was Acuta Capital Partners, an estimated $4.63M sold.
Based on aggregated 13F filings for Q2 2018.